background irritable bowel syndrome ibs is a complex syndrome that is difficult to managehere we present the evidence supporting medication treatments for specific ibs symptoms discuss evidencebased management of ibs with medications including dose regimens and adverse effects and review progress on research for new ibs treatmentssummary currently there is evidence to support improvements in specific ibs symptoms following treatment with loperamide psyllium bran lubiprostone linaclotide amitriptyline trimipramine desipramine citalopram fluoxetine paroxetine dicyclomine peppermint oil rifaximin ketotifen pregabalin gabapentin and octreotide and there are many new medications being investigated for the treatment of ibskey message of the medications with demonstrated improvements for ibs symptoms rifaximin lubiprostone linaclotide fiber supplementation and peppermint oil have the most reliable evidence supporting their use for the treatment of ibsonset of efficacy for the various medications has been noted to be as early as 6 days after initiation however the efficacy of most medications was not assessed prospectively at predefined periodsadditional studies of currently available and new medications are ongoing and are needed to better define their place in therapy and expand therapeutic options for the treatment of ibsthe most promising new medications for ibs include a variety of novel pharmacologic approaches most notably the dual μopioid receptor agonist and δopioid antagonist jnj27018966 2014 s karger ag basel